JP Morgan Put 100 ABT 21.02.2025/ DE000JT2SGC8 /
11/15/2024 10:21:11 AM | Chg.-0.004 | Bid11:51:12 AM | Ask11:51:12 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.078EUR | -4.88% | 0.084 Bid Size: 20,000 |
0.099 Ask Size: 20,000 |
Abbott Laboratories | 100.00 USD | 2/21/2025 | Put |
GlobeNewswire
8/6
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
6/6
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer